You are here

Jon Dobson
June 22, 2016

Device Tax Repeal, 21st Century Cures Included in House Health Care Task Force Report

WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement on the U.S. House of Representatives Health Care Task Force Report released today:

“AdvaMed greatly appreciates that the Task Force’s report highlights two important medical technology policy areas that have received bipartisan support:  Permanent repeal of the medical device tax and the important reforms to the FDA review process contained in the 21st Century Cures Act. We believe that these policies will support a more vibrant medical technology ecosystem and improve patient access to new treatments and cures.

“With the current suspension of the medical device tax, America’s medical technology companies are investing the recaptured revenue into important efforts such as increasing R&D and launching new products to advance patient care. Permanent repeal of the device tax would further strengthen those efforts and improve long-term planning by providing relief from this punitive tax policy.

“The 21st Century Cures Act includes a number of important regulatory reforms which will increase efficiency and predictability at FDA, including the creation of a streamlined pathway for breakthrough technologies used to treat serious illnesses.

“Device tax repeal and 21st Century Cures both have broad bipartisan support, and we stand ready to work toward passage of these issues with all members of Congress, the administration and other stakeholders.”

# # #

AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit